1(800) 380-9150
contact@halluxinc.com
Login
Username
Password
Remember Me
Forget?
Forget your password?
Username or E-mail
Remember Password?
Overview
News
Leadership
Clinical Trials
Contact
Overview
News
Leadership
Clinical Trials
Contact
NEWS
February 28, 2023: Hallux Reaches Enrollment Target in Onychomycosis Trial
September 22, 2022: Hallux Inc Opens Third Clinical Site to Evaluate Novel Onychomycosis Product Candidate
July 7, 2022: Hallux Inc Opens Second Clinical Site to Evaluate Novel Onychomycosis Product Candidate
May 18, 2022: Seth M. Birnbaum Joins Pharma Company Hallux Inc. Board of Directors
April 6, 2022: Hallux Inc. Announces Closing Of $9.4M Series A-2 Financing
January 12, 2022: Hallux Starts Phase 2 Clinical Study Of Novel Subungual Gel For Onychomycosis
November 8, 2016: Hallux Announces Start of Phase 2 Clinical Trial
Contact Us
We're not around right now. But you can send us an email and we'll get back to you, asap.
Not readable? Change text.
Send